Market Place
Sourcing Support
FDA Alerts Patients and Health Professionals to Nitrosamine Impurity Metformin
28 May 2020 //
PRNEWSWIRE
Contaminated diabetes drugs raise red flag for FDA oversight
28 May 2020 //
BIOPHARMADIVE
FDA Seeks Withdrawal of Heartburn Drugs Due to New Carcinogen Concerns
02 Apr 2020 //
RAPS
FDA warns of carcinogen found in diabetes drugs outside of US
11 Dec 2019 //
FOX10
NDMA investigation leads to cases discovered in diabetes treatment
10 Dec 2019 //
IN-PHARMATECHNOLOGIST
Class 2 Medicines recall: Ranitidine 150mg/10ml Oral Solution (EL (19)A/29)
25 Oct 2019 //
GOVUK
Sanofi and Dr Reddy’s join the ranitidine recall
25 Oct 2019 //
IN-PHARMATECHNOLOGY
Aurobindo chalks up new FDA manufacturing concerns
09 Oct 2019 //
FIERCE PHARMA
FDA cites solvent recovery firm as a player in the valsartan mess
16 Aug 2019 //
FIERCE PHARMA
The sartan saga: Recapping the recalls
15 Aug 2019 //
IN-PHARMATECHNOLOGY
NDEA & NDMA Impurities: Another Indian Manuf. Receives an FDA Warning Letter
13 Aug 2019 //
RAPS
FDA Sends Warning Letters to Aurobindo, API Repackers
03 Jul 2019 //
RAPS
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels
22 Mar 2019 //
RAPS
FDA updates on recalls of valsartan, losartan and irbesartan
20 Mar 2019 //
FDA
Pro Doc Limitée recalls 2 lots of irbesartan because of nitrosamine impurity
18 Mar 2019 //
HEALTH CANADA
Sartan issues continue as Macleods and Camber issue recalls
04 Mar 2019 //
IN-PHRAMTECHNOLOGIST
FDA finds new cancer-causing impurity in blood pressure pills
02 Mar 2019 //
CNBC
Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)
04 Feb 2019 //
EDQM
Enforcement Report - Week of January 23, 2019
23 Jan 2019 //
FDA
Irbesartan distributed by Solco Healthcare voluntarily recalled
19 Jan 2019 //
FDA
43 popular heart drugs found to contain carcinogens in Taiwan
19 Jan 2019 //
TAIWAN NEWS
Update on the review of CEP applications for sartans (18 Jan 2019)
18 Jan 2019 //
EDQM
EU Regulatory Roundup: UK NHS Calls for Changes to Pricing Legislation
11 Jan 2019 //
RAPS
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
Torrent Pharmaceuticals Expands Recall of Losartan Potassium Tablets
04 Jan 2019 //
FDA
Irbesartan blood pressure and heart medication recalled from pharmacies by MHRA
03 Jan 2019 //
GOV UK
Class 2 Medicines Recall: Actavis recall of batches of Irbesartan / HCTZ Tablets
03 Jan 2019 //
GOV UK
Aurobindo Pharma USA recalls 80 lots of blood pressure drug from America
02 Jan 2019 //
ECONOMIC TIMES
Taiwan takes 3 million blood pressure tablets off shelves due to cancer risk
29 Dec 2018 //
TAIWAN NEWS
FDA updates on ARB recalls including valsartan, losartan and irbesartan
21 Dec 2018 //
FDA
Torrent Pharmaceuticals Recalls Losartan Potassium Tablets
21 Dec 2018 //
FDA
Enforcement Report - Week of December 19, 2018
19 Dec 2018 //
FDA
FDA updates NDMA and NDEA detection methods, posting of ZHP warning letter
12 Dec 2018 //
FDA
Walmart and Aurobindo sued as litigation mounts over contaminated blood pressure drugs
08 Dec 2018 //
FIERCE PHARMA
Mylan to recall all batches of blood pressure medicine valsartan in U.S.
05 Dec 2018 //
REUTERS
MHRA recalls Valsartan blood pressure and heart medication from pharmacies
30 Nov 2018 //
GOV UK
Mylan Valsartan medications voluntarily recalled due to an impurity
29 Nov 2018 //
HEALTH CANADA
Valsartan recall expands to Mylan, Teva products
29 Nov 2018 //
FIERCE PHARMA
Valsartan recall expands to Mylan, Teva products
28 Nov 2018 //
FIERCE PHARMA
Teva to recall certain blood pressure medicine in U.S
28 Nov 2018 //
REUTERS
Analysis of valsartan batches recalled in July 2018 confirms NDMA contamination
25 Nov 2018 //
SWISSMEDIC
TGA Issues Recall of Mylan Australia`s Dilart and Dilart HCT (valsartan)
25 Nov 2018 //
TGA
Mylan recalls batches of blood pressure medicine in U.S.
22 Nov 2018 //
REUTERS
EDQM prohibits use of Mylan`s valsartan in EU medicines following impurity
20 Nov 2018 //
PHARMABIZ
EU cracks down on blood pressure medicine made by Mylan
20 Nov 2018 //
REUTERS
Sandoz recalls losartan products that contain impurity
12 Nov 2018 //
FIERCE PHARMA
FDA updates on angiotensin II receptor blocker (ARB) recalls
09 Nov 2018 //
FDA
Aurobindo recalls hypertension drug in US, cites cancer risk
02 Nov 2018 //
DNA INDIA
FDA Alerts to Recalls Over Non-Valsartan Product Found to Contain Impurities
02 Nov 2018 //
RAPS
FDA warns some irbesartan tablets in U.S. contain impurity
01 Nov 2018 //
FIERCE PHARMA
Sciegen Pharmaceuticals Recalls Irbesartan Due to Trace Amounts of NDEA
31 Oct 2018 //
FDA
Aurobindo Pharma Recalls Irbesartan due to Trace NDEA Impurity
30 Oct 2018 //
FDA
